• Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register

SCIENTIFIC COMMITTEE

    view profile

    Silvia García Méndez

    University of Vigo, Spain
    view profile

    Checler Frédéric

    University of Nice-Sophia-Antipolis, France
    view profile

    Ottavio Arancio

    Columbia University, USA
    view profile

    Hiskias G.Keizer

    AMRIF, The Netherlands

Silvia García Méndez

University of Vigo

Spain

Silvia García Méndez received a Ph.D. in Information and Communication Technologies from the University of Vigo. Since 2015, she has worked as a researcher within the Information Technologies Group - atlanTTic at the University of Vigo. She is currently the co-director of the Natural Language Processing area. She has contributed to quality scientific dissemination in prestigious journals and national and international conferences. Her scientific production is completed with numerous European, national, regional, and technology transfer projects with the company, as well as teaching innovation projects. She also collaborates with national and international research groups (Natural Language Generation and other areas of Computational Linguistics (CLAN) group, University of Aberdeen, Scotland; Laboratoire d'Informatique et Systèmes (LIS), Aix-Marseille University, France; Centro de Robótica e Sistemas Autónomos (CRAS), Politécnico do Porto, Portugal; University of Beni Suef, Egypt; Procesamiento del Lenguaje Natural y Sistemas de Información (GPLSI) group, University of Alicante, Spain). Her awards and honors include the University of Vigo Extraordinary Doctorate Award (2022), the 11th Vodafone Connecting for Good Award for Innovation in Telecommunications (2017), and the 2nd Call of Indra and Fundación Universia Grants for Accessible Technologies Research Projects (2017). It is worth highlighting her collaboration with AFAGA Alzheimer to reduce the digital divide for older adults; Xunta de Galicia for the development of accessibility solutions; TEAVI Association to improve the classroom environment; and the European KA2 Strategic Partnerships Program for universal accessibility in cultural resources for lifelong education. Summing up, her research interests include Artificial Intelligence-based solutions exploiting Natural Language Processing techniques and Machine Learning algorithms

Checler Frédéric

University of Nice-Sophia-Antipolis

France

F. Checler received his PhD in Cellular and Molecular Pharmacology from University of Nice-Sophia-Antipolis (1983). He is now research director at INSERM. F. Checler belongs to the laboratory of Excellence DistALZ (Development of Innovative STrategies for translational Approach in ALZheimer Disease). He was the first president of the scientific committee of the “Ligue Européenne Contre la Maladie d’Alzheimer”.
His honors include: the BioMerieux award (1997); 1999 MHRI Kearney Fellow Award, Mental Health Research Institute; the Charles-Louis de Saulces de Freycinet Award, French National Academy of Science (2002); the “Grand Prix” Jaffé of the French Academy of Sciences (2013); “Grand prix” of Pompidou foundation 2014; Medal of the Departmental council; Medal of the University of Nice-Sophia Antipolis (2013, 2014). He has been elected « foreign corresponding member of the Brazilian Academy of Sciences 

Ottavio Arancio

Columbia University

USA

Dr. Ottavio Arancio, a Professor at Columbia University, received his MD/Ph.D from the University of Pisa (Italy). Dr Arancio is a cellular neurobiologist who has pioneered the field of mechanisms of synaptic dysfunction in Alzheimer’s disease and traumatic brain injury. His laboratory has focused primarily on events triggered by oligomeric proteins including amyloid-beta and tau. These studies have suggested new links between synaptic dysfunction and dementia, both for understanding the etiopathogenesis of Alzheimer’s disease and traumatic brain injury, and for developing therapies aiming to improve the cognitive symptoms.

Hiskias G.Keizer

AMRIF

The Netherlands

Hiskias G. Keizer, trained as a medical biologist, earned his PhD at the medical faculty of the Free University of Amsterdam. Subsequently, he spent 20 years as a scientist in a pharmaceutical company developing drugs for the central nervous system, and 20 years as a biochemist developing functional foods for various indication, including Alzheimer’s disease. Four years ago, he joined AMRIF to develop alkaline phosphatase, a potent anti-ageing drug, as a treatment for age-dependent neurodegeneration. Over the last 25 years, he has focused on biochemistry regulating cellular homeostasis and ageing. This led to the “CPT2 cascade hypothesis for Alzheimer's disease”.

 

 

Contact Information

+1-408-352-1010
[email protected]
+1-408-352-1010

Locate US

5201 Great America Pkwy #320,
Santa Clara, CA 95054,
United States

Keep me Updated..!


Copyrights © 2020-21 Innovinc International, All Rights Reserved